Abstract:We have studied factors affecting the catalytic activity of dihydroorotase (EC 3.5.2.3), purified as part of a multienzymatic protein which contains carbamyl phosphate synthetase, aspartate transcarbamylase, and dihydroorotase (ME pyr1-3) and which initiates de novo pyrimidine biosynthesis in mouse Ehrlich ascites carcinoma. The apparent Km value for N-carbamyl-L-aspartate increases by 2 orders of magnitude as the pH increases from 7.0 to 8.3, consistent with equilibration of dihydroorotase (E) between four states of protonation (E in equilibrium EH in equilibrium EH2 equilibrium EH3), where EH3 is the only catalytically active form of dihydroorotase for the biosynthetic reaction, having a Km for N-carbamyl-L-aspartate of 30 micro M. The apparent Km for L-dihydroorotate shows a converse dependence upon pH, remaining relatively constant at alkaline pH and increasing progressively as the pH is decreased below 7.0. These data are consistent with the above model if E and EH are catalytically active for the degradative reaction, both having Km values of 4.4 micro M for L-5,6-dihydroorotate. The D isomers of carbamylaspartate and dihydroorotate are also substrates for dihydroorotase. At pH 7.33, the apparent Km values for N-carbamyl-L-aspartate and N-carbamyl-D-aspartate are 247 and 204 micro M, respectively, but the Vmax for N-carbamyl-D-aspartate is only 1.7% of that obtained with N-carbamyl-L-aspartate. Orotate and a series of 5-substituted derivatives are competitive inhibitors of dihydroorotase. At pH 7.27, the apparent Ki for orotate using N-carbamyl-L-aspartate as substrate is 170 micro M and with L-5,6-dihydroorotate as substrate, the apparent Ki value is 9.6 micro M, suggesting that the enzyme exists in different forms in the presence of each substrate. Dihydroorotase is inhibited in a time-dependent manner by 50 mM L-cysteine and the presence of N-carbamyl-L-aspartate or L-5,6-dihydroorotate protects against this ultimately complete inactivation. 2-Mercaptoacetate, 2-mercaptoethylamine, 3-mercaptopropionate, and L-2,3-diaminopropionate have a similar although less potent inhibitory effect. To account for the data obtained, we propose a model for the equilibria existing between various protonated forms of dihydroorotase which is consistent with the pH dependencies of the apparent Km values observed and the Vmax values observed previously (Christopherson, R.I., and Jones, M.E. (1979) J. Biol. Chem. 254, 12506-12512). In addition, a catalytic mechanism is presented for the interconversion of N-carbamyl-L-aspartate and L-5,6-dihydroorotate.

Specific Anion Effects on Urease Activity: A Hofmeister Study

The effect of three urease inhibitors on H. pylori viability, urease activity and urease gene expression

Lead Molecules for Targeted Urease Inhibition: An Updated Review from 2010 -2018

Targeting the Protein Tunnels of the Urease Accessory Complex: A Theoretical Investigation

Exploration of thiazine Schiff bases as promising urease inhibitors: Design, synthesis, enzyme inhibition, kinetic analysis, ADME/T evaluation, and molecular docking studies

The effects of pH and inhibitors upon the catalytic activity of the dihydroorotase of multienzymatic protein pyr1-3 from mouse Ehrlich ascites carcinoma

A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations

Anion Binding to Ubiquitin and Its Relevance to the Hofmeister Effects

Identification of (N-aryl-N-arylsulfonyl)aminoacetohydroxamic acids as novel urease inhibitors and the mechanism exploration

The Structure of the Elusive Urease-Urea Complex Unveils the Mechanism of a Paradigmatic Nickel-Dependent Enzyme.

Molecular Docking and Molecular Dynamics Simulations of the Urease Inhibitory Activity of 2,3‐Dihydroxybenzohydrazide Derivatives

The pH of urea solutions

Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori

Preferential Adsorption of Prominent Amino Acids in the Urease Enzyme of Sporosarcina pasteurii on Arid Soil Components: A Periodic DFT Study

Is Bismuth(III) able to inhibit the activity of urease? Puzzling results in the quest for soluble urease complexes for agrochemical and medicinal applications

Design and discovery of urease and Helicobacter pylori inhibitors based on benzofuran/benzothiophene-sulfonate and sulfamate scaffolds for the treatment of ureolytic bacterial infections

Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review

Metallochaperone UreG serves as a new target for design of urease inhibitor: A novel strategy for development of antimicrobials

The Synthesis, Structure and Activity Evaluation of Pyrogallol and Catechol Derivatives As Helicobacter Pylori Urease Inhibitors

Extra precision glide docking, free energy calculation and molecular dynamics studies of 1,2-diarylethane derivatives as potent urease inhibitors

Unraveling Binding Mechanism and Stability of Urease Inhibitors: A QM/MM MD Study